Internal Medicine, Pulmonary Disease · Wyandotte, MI
NPI
1043274814
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2333 Biddle St
Wyandotte, MI, 48192
Phone (734) 324-3528
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
2,710 services
Medicare patients, 2024
510
Average age 75
Drug cost, 2024
$1.4M
1,552 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark I Pensler was code 99232 (hospital e&m - subsequent), 986 times for 236 patients. In total Mark I Pensler billed 2,710 services in 25 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 986 | 236 | $62.80 | $62K |
| 99213 Office E&M - Established | Office | 365 | 178 | $66.08 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 361 | 166 | $13.01 | $4,698 |
| 99214 Office E&M - Established | Office | 202 | 122 | $93.29 | $19K |
| 99222 Hospital E&M - Initial | Facility | 150 | 126 | $101.45 | $15K |
| 99223 Hospital E&M - Initial | Facility | 128 | 109 | $135.72 | $17K |
| 94010 Pulmonary Function Testing | Office | 121 | 95 | $19.42 | $2,349 |
| 94726 Pulmonary Function Testing | Facility | 77 | 71 | $9.09 | $700 |
| 94010 Pulmonary Function Testing | Facility | 68 | 62 | $6.42 | $437 |
| 94729 Pulmonary Function Testing | Facility | 63 | 61 | $6.75 | $425 |
| 99204 Office E&M - New | Office | 29 | 29 | $119.81 | $3,475 |
| 94727 Pulmonary Function Testing | Facility | 25 | 25 | $9.31 | $233 |
| 94618 Pulmonary Function Testing | Facility | 23 | 20 | $17.26 | $397 |
| 95806 Sleep Study | Facility | 20 | 20 | $33.34 | $667 |
| 94060 Pulmonary Function Testing | Facility | 20 | 20 | $7.37 | $147 |
By year: 2022 $204K for 2,950 services; 2023 $152K for 2,291 services; 2024 $157K for 2,710 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark I Pensler prescribed most often to Medicare patients was Prednisone, with 208 prescriptions and refills. In total Mark I Pensler wrote 1,552 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 208 | 232 | 98 | $1,232 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 176 | 323 | 99 | $9,445 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 169 | 401 | 63 | $243K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 90 | 219 | 38 | $23K |
| Spiriva Respimat Tiotropium Bromide | 72 | 187 | 28 | $90K |
| Breo Ellipta Fluticasone/Vilanterol | 68 | 158 | 26 | $59K |
| Doxycycline Hyclate Generic | 57 | 57 | 42 | $268 |
| Tiotropium Bromide Generic | 48 | 134 | 15 | $52K |
| Roflumilast Generic | 48 | 102 | 13 | $5,125 |
| Ventolin Hfa Albuterol Sulfate | 46 | 99 | 23 | $7,283 |
| Fluticasone Propionate Generic | 36 | 87 | 19 | $592 |
| Pirfenidone Generic | 34 | 34 | Under 11 | $80K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 31 | 88 | 15 | $9,780 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 28 | 76 | 11 | $15K |
| Symbicort Budesonide/Formoterol Fumarate | 28 | 64 | 11 | $13K |
Brand drugs: 799 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mark I Pensler were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.